Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 156

Results For "RMAT"

1996 News Found

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Biotech | May 10, 2022

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion

Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need


Lupin selects HPE GreenLake edge-to-cloud platform
Digitisation | May 09, 2022

Lupin selects HPE GreenLake edge-to-cloud platform

Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss


Oncocyte completes validation of Therasure transplant monitor test
Biotech | May 08, 2022

Oncocyte completes validation of Therasure transplant monitor test

Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions


SKS Hospital, Salem installs Carestream’s detector for paediatric studies
Hospitals | May 07, 2022

SKS Hospital, Salem installs Carestream’s detector for paediatric studies

This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients


Thieme EIDO Healthcare launches digital consent platform with Indian Medical Association
Digitisation | May 06, 2022

Thieme EIDO Healthcare launches digital consent platform with Indian Medical Association

The aim is to bring patient consent tools in a digital format in addition to a paper format which is not just a need of the current times but also a way forward


USFDA limits use of J&J Covid-19 vaccine to certain individuals
News | May 06, 2022

USFDA limits use of J&J Covid-19 vaccine to certain individuals

The FDA has determined that the known and potential benefits of the vaccine for the prevention of Covid-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved vaccines are not accessible


USFDA permits marketing for new test to improve diagnosis of Alzheimer's disease
News | May 05, 2022

USFDA permits marketing for new test to improve diagnosis of Alzheimer's disease

According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills


Fear of fourth wave drives Indians to search Covid health services
News | May 05, 2022

Fear of fourth wave drives Indians to search Covid health services

Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit
Biotech | May 04, 2022

Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit

At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes